SEARCH

SEARCH BY CITATION

References

  • 1
    Ueda T, Kikuchi A, Ohga N, Yamamoto J, Takai Y. Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J Biol Chem 1990; 265: 937380.
  • 2
    Fukata M, Kaibuchi K. Rho-family GTPases in cadherin-mediated cell–cell adhesion. Nat Rev Mol Cell Biol 2001; 2: 88797.
  • 3
    Titus B, Schwartz MA, Theodorescu D. Rho proteins in cell migration and metastasis. Crit Rev Eukaryot Gene Expr 2005; 15: 10314.
  • 4
    DerMardirossian C, Bokoch GM. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005; 15: 35663.
  • 5
    Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 1999; 11: 54554.
  • 6
    Robbe K, Otto-Bruc A, Chardin P, Antonny B. Dissociation of GDP dissociation inhibitor and membrane translocation are required for efficient activation of Rac by the Dbl homology-pleckstrin homology region of Tiam. J Biol Chem 2003; 278: 475662.
  • 7
    Zalcman G, Dorseuil O, Garcia-Ranea JA, Gacon G, Camonis J. RhoGAPs and RhoGDIs, (His)stories of two families. Prog Mol Subcell Biol 1999; 22: 85113.
  • 8
    Gildea JJ, Seraj MJ, Oxford G et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002; 62: 641823.
  • 9
    Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson HF Jr. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 2004; 10: 38006.
  • 10
    Ota T, Maeda M, Suto S, Tatsuka M. LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane. Mol Carcinog 2004; 39: 20620.
  • 11
    Zhang Y, Zhang B. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 2006; 66: 55928.
  • 12
    Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 1990; 265: 187136.
  • 13
    Bremer EG, Schlessinger J, Hakomori S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 1986; 261: 243440.
  • 14
    Yates AJ, Saqr HE, Van Brocklyn J. Ganglioside modulation of the PDGF receptor. A model for ganglioside functions. J Neurooncol 1995; 24: 6573.
  • 15
    Yates AJ, Rampersaud A. Sphingolipids as receptor modulators. An overview. Ann N Y Acad Sci 1998; 845: 5771.
  • 16
    Sun P, Wang XQ, Lopatka K, Bangash S, Paller AS. Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling. J Invest Dermatol 2002; 119: 10717.
  • 17
    Choi HJ, Chung TW, Kang SK et al. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression – transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Glycobiology 2006; 16: 57383.
  • 18
    Wang P, Wu P, Zhang J, Sato T, Yamagata S, Yamagata T. Positive regulation of tumor necrosis factor-alpha by ganglioside GM3 through Akt in mouse melanoma B16 cells. Biochem Biophys Res Commun 2007; 356: 43843.
  • 19
    Wang P, Yang X, Wu P et al. GM3 signals regulating TNF-alpha expression are mediated by Rictor and Arhgdib in mouse melanoma B16 cells. Oncology 2007; 73: 4308.
  • 20
    Miura Y, Kainuma M, Jiang H, Velasco H, Vogt PK, Hakomori S. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci USA 2004; 101: 162049.
  • 21
    Uemura S, Kabayama K, Noguchi M, Igarashi Y, Inokuchi J. Sialylation and sulfation of lactosylceramide distinctly regulate anchorage-independent growth, apoptosis, and gene expression in 3LL Lewis lung carcinoma cells. Glycobiology 2003; 13: 20716.
  • 22
    Iwabuchi K, Handa K, Hakomori S. Separation of “glycosphingolipid signaling domain” from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem 1998; 273: 3376673.
  • 23
    Wu Y, Moissoglu K, Wang H et al. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc Natl Acad Sci USA 2009; 106: 580712.
  • 24
    Wang X-Q, Sun P, Paller AS. Ganglioside GM3 Blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem 2003; 278: 487708.
  • 25
    Boivin D, Bilodeau D, Beliveau R. Regulation of cytoskeletal functions by Rho small GTP-binding proteins in normal and cancer cells. Can J Physiol Pharmacol 1996; 74: 80110.
  • 26
    Wang L, Takaku S, Wang P et al. Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content. Glycoconj J 2006; 23: 30315.
  • 27
    Chauhan AK, Li YS, Deuel TF. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci USA 1993; 90: 67982.
  • 28
    Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU, Hung MC. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene 1999; 18: 80711.
  • 29
    Chigorno V, Pitto M, Cardace G et al. Association of gangliosides to fibroblasts in culture: A study performed with GM1 [14C]-labelled at the sialic acid acetyl group. Glycoconj J 1985; 2: 27991.
  • 30
    Svennerholm L, Fredman P. A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 1980; 617: 97109.
  • 31
    Nakamura Y, Colburn NH, Gindhart TD. Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis 1985; 6: 22935.
  • 32
    Nomura T, Takizawa M, Aoki J et al. Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain. J Biol Chem 1998; 273: 135707.
  • 33
    Garofalo T, Sorice M, Misasi R et al. A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3. Involvement of serine phosphorylation and protein kinase c delta translocation. J Biol Chem 1998; 273: 3515360.
  • 34
    Wang L, Wang Y, Sato T, Yamagata S, Yamagata T. Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells. Biochem Biophys Res Commun 2008; 371: 2305.
  • 35
    Alessi DR, James SR, Downes CP et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 1997; 7: 2619.
  • 36
    Bremer EG, Hakomori S. GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function. Biochem Biophys Res Commun 1982; 106: 7118.
  • 37
    Hanai N, Dohi T, Nores GA, Hakomori S. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J Biol Chem 1988; 263: 6296301.
  • 38
    Wang XQ, Sun P, Go L, Koti V, Fliman M, Paller AS. Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling. J Invest Dermatol 2006; 126: 268796.
  • 39
    Zhang Y, Rosado LAR, Moon SY, Zhang B. Silencing of D4-GDI Inhibits Growth and Invasive Behavior in MDA-MB-231 Cells by Activation of Rac-dependent p38 and JNK Signaling. J Biol Chem 2009; 284: 1295665.
  • 40
    Jiang K, Sun J, Cheng J, Djeu JY, Wei S, Sebti S. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol Cell Biol 2004; 24: 556576.